Sub-chronic administration of the dopamine D1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: Stable therapeutic effects and wearing-off dyskinesia

Psychopharmacology

Volumn 146, Issue 3, 1999, Pages 328-334

  Andringa, G ^a,b   Stoof, J C ^b   Cools, A R ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Behaviour; Benzazepine; D1 agonist; D1 antagonist; MPTP; Parkinson's disease; SKF 83959

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 (4 HYDROXYPHENYL) 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 6 CHLORO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 2,3,4,5 TETRAHYDRO H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; LEVODOPA; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHETOSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DYSTONIA; MALE; NONHUMAN; OROFACIAL DYSKINESIA; PARKINSON DISEASE; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; ANTIPARKINSON AGENTS; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; LEVODOPA; MACACA MULATTA; MALE; MPTP POISONING; PARKINSON DISEASE; RECEPTORS, DOPAMINE D1;

EID: 0042032778     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051124     Document Type: Article

References (31)

1. 1 receptor efficacy. Eur J Pharmacol 188:335-347
2. 1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 364:33-41
3. 1 agonist SKF 81927. Behav Pharmacol 10:163-173
4. 1 agonist SKF 82958. Behav Pharmacol 10:175-182
5. 1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259-267
6. Bedard PJ, Mancilla BG, Blanchette P, Gagnon C, Di PT (1992) Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us? Can J Neurol Sci 19:134-137
7. 2 agonist (U-91356 A) in MPTP-exposed monkeys. J Pharmacol Exp Ther 272:854-859
8. 1 receptor desensitization profile in MPTP-lesioned primates. Eur J Pharmacol 309:13-20
9. 123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse 27:183-190
10. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin JJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2.3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550
11. Chase TN, Mouradian MM, Engber TM (1993) Motor response complications and the function of striatal efferent systems. Neurology 43:S23-S27
12. Clarke CE, Sambrook MA, Mitchell IJ, Crossman AR (1987) Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP). J Neurol Sci 78:273-280
13. 1 receptor. Eur J Pharmacol 199:209-219
14. 1-like" dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116:2120-2126
15. 1-like" receptors that inhibits dopamine-sensitive adenylyl cyclase. Eur J Pharmacol 234:135-136
16. Ellenbroek BA, Knobbout DA, Cools AR (1997) The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm. Psychopharmacology 129:112-120
17. Elsworth JD, Deutch AY, Redmond-DE J. Siadek-JR J, Roth RH (1987) Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. Life Sci 40:193-202
18. 1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset. Psychopharmacology 117:275-286
19. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol 246:39-44
20. Jaspers RM, Berkelbach-van DS, Cools AR (1989) Progressive pathology of the caudate nucleus, the substantia nigra pars reticulata and the deeper layers of the colliculus superior: acute behavioural and metabolic effects of intrastriatal kainic acid. Neuroscience 28:159-169
21. Johnson BJ, Peacock V, Schneider JS (1995) Dihydrexidine, a full D, dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys. Pharmacol Biochem Behav 51:617-622
22. Langston JW, Ballard P (1984a) Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci 11:160-165
23. Langston JW, Langston EB, Irwin I (1984b) MPTP-induced parkinsonism in human and non-human primates.- clinical and experimental aspects. Acta Neurol Scand Suppl 100:49-54
24. Marsden CD, Parkes JD (1976) "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1:292-296
25. Miczek KA, Gold LH (1983) d-Amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion, and stereotypies. Psychopharmacology 81:183-190
26. Nutt JG (1994) Levodopa: rational and irrational pharmacology [editorial]. Ann Neurol 36:4-5
27. Schneider JS (1989) Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage. Pharmacol Biochem Behav 34:193-196
28. 1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. J Pharmacol Exp Ther 276:150-160
29. Smith RD, Zhang Z, Kurlan R, McDermott M, Gash DM (1993) Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience 52:7-16
30. Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366-368
31. 1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents. Eur J Pharmacol 242:165-172